2025 -- H 5432 SUBSTITUTE A | |
======== | |
LC000796/SUB A | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2025 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
| |
Introduced By: Representatives Tanzi, Morales, Spears, McGaw, Handy, Fogarty, Ajello, | |
Date Introduced: February 12, 2025 | |
Referred To: House Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled "Insurance |
2 | Coverage for Mental Illness and Substance Use Disorders" is hereby amended to read as follows: |
3 | 27-38.2-1. Coverage for treatment of mental health and substance use disorders. |
4 | (a) A group health plan and an individual or group health insurance plan shall provide |
5 | coverage for the treatment of mental health and substance use disorders under the same terms and |
6 | conditions as that coverage is provided for other illnesses and diseases. |
7 | (b) Coverage for the treatment of mental health and substance use disorders shall not |
8 | impose any annual or lifetime dollar limitation. |
9 | (c) Financial requirements and quantitative treatment limitations on coverage for the |
10 | treatment of mental health and substance use disorders shall be no more restrictive than the |
11 | predominant financial requirements applied to substantially all coverage for medical conditions in |
12 | each treatment classification. |
13 | (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of |
14 | mental health and substance use disorders unless the processes, strategies, evidentiary standards, |
15 | or other factors used in applying the non-quantitative treatment limitation, as written and in |
16 | operation, are comparable to, and are applied no more stringently than, the processes, strategies, |
17 | evidentiary standards, or other factors used in applying the limitation with respect to |
18 | medical/surgical benefits in the classification. |
| |
1 | (e) The following classifications shall be used to apply the coverage requirements of this |
2 | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4) |
3 | Outpatient, out-of-network; (5) Emergency care; and (6) Prescription drugs. |
4 | (f) Medication-assisted treatment or medication-assisted maintenance services of substance |
5 | use disorders, opioid overdoses, and chronic addiction, including methadone, buprenorphine, |
6 | naltrexone, or other clinically appropriate medications, is included within the appropriate |
7 | classification based on the site of the service. |
8 | (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine when |
9 | developing coverage for levels of care for substance use disorder treatment. |
10 | (h) Patients with substance use disorders shall have access to evidence-based, non-opioid |
11 | treatment for pain, therefore coverage shall apply to medically necessary chiropractic care and |
12 | osteopathic manipulative treatment performed by an individual licensed under § 5-37-2. |
13 | (i) Parity of cost-sharing requirements. Regardless of the professional license of the |
14 | provider of care, if that care is consistent with the provider’s scope of practice and the health plan’s |
15 | credentialing and contracting provisions, cost sharing for behavioral health counseling visits and |
16 | medication maintenance visits shall be consistent with the cost sharing applied to primary care |
17 | office visits. |
18 | (j) No health insurers shall require prior authorization, for in-network inpatient and in- |
19 | network outpatient mental health or substance use disorder services. The office of the health |
20 | insurance commissioner shall promulgate rules and regulations and conduct oversight and |
21 | enforcement actions necessary to implement this subsection, including the imposition of fines for |
22 | violations. |
23 | SECTION 2. This act shall take effect on January 1, 2026. |
======== | |
LC000796/SUB A | |
======== | |
| LC000796/SUB A - Page 2 of 3 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
*** | |
1 | This act would prohibit health insurance providers from requiring preauthorization for in- |
2 | network mental health or substance use disorder services. |
3 | This act would take effect on January 1, 2026. |
======== | |
LC000796/SUB A | |
======== | |
| LC000796/SUB A - Page 3 of 3 |